1. Rosenberg, B. (1999) Platinum complexes for the treatment of cancer: why the search goes on Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B. ed.) Wiley-VCH, Basel, Switzerland, 3–27.
2. Zamble, D. B., Jacks, T., Lippard, S. J. (1998) p53-dependent and -independent response to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci U S A, 95, 6163–6168.
3. Pestell, K. E., Hobbs, S. M., Titley, J. C., Kelland, L. R., Walton, M. I. (2000) Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol Pharm, 57, 503–511.
4. Gonzalez, V. M., Fuertes, M. A. Alonso, C., Perez, J. M. (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol, 59, 657–663.
5. Lieberthal, W., Triaca, V., Levine, J. (1996) Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol, 270, F700–F708.